drugset / Trial / NCT04908462
To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
The study is designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of Oral AL01211 in healthy volunteers
Timeline
- Start
- 2021-06-08
- Primary completion
- 2022-06-20
- Completion
- 2022-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AL01211 | Small molecule | 2 mg | Oral |
| Subject | AL01211 | Small molecule | 60 mg | Oral |